Latham & Watkins Advises Evolv Technology in US$1.7 Billion deSPAC Merger With Newhold Investment Corp.

A multidisciplinary team represents the AI security company in the SPAC transaction that will make Evolv a publicly traded company.

March 08, 2021

Evolv Technology (Evolv), an AI touchless security screening company, and NewHold Investment Corp. (NASDAQ: NHIC), a special purpose acquisition company (SPAC), have announced they have entered into a definitive merger agreement for a business combination that will result in Evolv becoming a publicly traded company. It is anticipated that Evolv will trade on the NASDAQ with the ticker symbol “EVLV” after the deal closes in Q2 2021.

Latham & Watkins represents Evolv Technology in the transaction with a corporate deal team led by Houston partner Ryan Maierson and Boston partners Stephen Ranere and Daniel Hoffman, with Boston associates Stefanie Vincent, Martha Anderson, and Nuri Ruzi. Advice was also provided on antitrust matters by Washington, D.C. counsel Peter Todaro and Joseph Simei; on tax matters by New York partner Lisa Watts, with New York associate Eric Kamerman; on benefits and compensation matters by New York partner Jennifer Pepin; on intellectual property matters by Boston partner Sarah Gagan, with Boston associate Deborah Hinck.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.